GlassScriptPhysician profile
Randall Peterson
NPI 1902124308
$1,593.77
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $771 · 2020: $493 · 2021: $316 · 2022: $14.23.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $294.44 | 2019-2020 | |
| Glaxosmithkline, LLC. | $210.91 | 2019-2021 | |
| Novo Nordisk INC | $195.62 | 2019-2021 | |
| Abbvie INC. | $175.62 | 2021-2022 | |
| Amgen INC. | $168.79 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $164.02 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.85 | 2019-2020 | |
| Amarin Pharma, INC. | $58.14 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.76 | 2019-2021 | |
| Lilly USA, LLC | $53.54 | 2019-2020 | |
| Eisai INC. | $38.52 | 2020-2021 | |
| Esperion Therapeutics, INC. | $24.42 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $22.50 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.61 | 2020 | |
| Seqirus USA INC | $12.27 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.95 | 2021 | |
| Boston Scientific Corporation | $11.75 | 2019 | |
| Merck Sharp & Dohme LLC | $11.55 | 2019 | |
| Pfizer INC. | $11.51 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.